文献速递眼底病与葡萄膜炎

欧洲年龄相关性黄斑变性的患病率与发病率:系统综述与荟萃分析

Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis.
PubMed 文献 · Br J Ophthalmol · 2019-11-11

该系统综述与荟萃分析纳入1996年以来发表的22项患病率研究和4项发病率研究,估算60岁及以上人群早期或中期AMD汇总患病率为25.3%(95%CI 18.0%至34.4%),任何晚期AMD为2.4%(95%CI 1.8%至3.3%);任何晚期AMD年汇总发病率为每1000人1.4例(95%CI 0.8至2.6)。

要点

  • 60岁及以上人群早期或中期AMD汇总患病率为25.3%(95%CI 18.0%至34.4%)。
  • 60岁及以上人群任何晚期AMD汇总患病率为2.4%(95%CI 1.8%至3.3%)。

核心结论

  • 晚期AMD患者的监测和治疗将需要额外医疗资源及未来数十年的周密医疗规划。

研究设计与样本

  • 基于流行病学观察性研究荟萃分析指南对AMD患病率和发病率进行系统综述。
  • 纳入1996年以来发表的22项患病率研究和4项发病率研究。
  • 对时间趋势、年龄、国家、地区、性别和AMD分类系统进行荟萃分析和荟萃回归。
  • 基于欧盟统计局人口预测将汇总患病率估计外推至2050年。

主要发现

  • 60岁及以上人群早期或中期AMD汇总患病率为25.3%(95%CI 18.0%至34.4%)。
  • 60岁及以上人群任何晚期AMD汇总患病率为2.4%(95%CI 1.8%至3.3%)。
  • 老年人群中患病率显著增加。
  • 任何晚期AMD年汇总发病率为每1000人1.4例(95%CI 0.8至2.6)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: Age-related macular degeneration (AMD) is the main cause of visual impairment and blindness in Europe. A further increase in the number of affected persons is expected and current European data are needed for healthcare resource planning. METHODS: We performed a systematic review on the prevalence and incidence of AMD based on the meta-analysis of observational studies in epidemiology guideline. Meta-analysis and meta-regression on time-trends, age, countries, regions, sex and classification systems for AMD were performed. Based on Eurostat population projections, the pooled prevalence estimates were extrapolated to the year 2050. RESULTS: Twenty-two prevalence and four incidence studies published since 1996 were included. Our pooled prevalence estimate of early or intermediate AMD and any late AMD in those 60 years and older was 25.3% (95% CI 18.0% to 34.4%) and 2.4% (95% CI 1.8% to 3.3%), respectively. A significant increase in prevalence was seen in older populations. In the meta-analysis of incidence, the pooled annual incidence of any late AMD was 1.4 per 1 000 individuals (95% CI 0.8 to 2.6). Overall, the number of EU inhabitants with any AMD is expected to increase from 67 to 77 million until 2050. Incident late AMD is estimated to increase from 400 000 per year today to 700 000 per year in 2050. CONCLUSIONS: Approximately 67 million people in the EU are currently affected by any AMD and, due to population ageing, this number is expected to increase by 15% until 2050. Monitoring and treatment of people with advanced disease stages will require additional healthcare resources and thorough healthcare planning in the years and decades to come.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Li JQ, Welchowski T, Schmid M, et al. Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis. Br J Ophthalmol. 2019. PMID: 31712255. doi:10.1136/bjophthalmol-2019-314422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。